Medical Disorders
Resources
Basic InformationLookupsLatest News
Strict Blood Pressure Limits for Kids Tied to Heart Health LaterAlmost Half of Young Asthma Patients Misuse Inhalers'Superbugs' Hang Out on Hospital PatientsHealth Tip: Understanding the Tetanus ShotHealth Tip: Earache Home CareListeria Outbreak Linked to Deli Meats, Cheeses in 4 StatesWill You Get Fat? Genetic Test May TellFood Allergies Can Strike at Any AgeWhy a Knee Replacement Can Go BadExperimental Blood Thinner May Help Prevent Stroke, Without the Bleeding RiskBuyer Beware When Purchasing Medical Test StripsEgg Allergy? Don't Let That Stop You From Getting VaccinatedGene Therapy Might Prove a Cure for 'Bubble Boy' DiseaseTwo Lives Saved in Rare 'Paired' Liver DonationHealth Tip: Stopping NosebleedsKids Can Get UTIs, TooWhy More Patients Are Surviving an AneurysmCommon Diabetes Drug May Also Shield Kidneys, Heart'Added Sugars' Label on Foods Could Save Many LivesCPAP Brings Longer Life for Obese People With Sleep Apnea: StudyYoung Athletes Need to Be Sidelined After Bout of MonoPre-Cut Melons at Kroger, Walmart, Other Stores May Carry SalmonellaCDC Says Ground Beef Is Source of E. coli Outbreak, Cases Rise to 109AHA News: Is Yoga Heart-Healthy? It's No Stretch to See Benefits, Science SuggestsFDA Orders Label Warning on Alcohol Use With 'Female Viagra'Could Treating Gut Bacteria Help Ease Autism Symptoms?Hospital Privacy Curtains Could Be Breeding Ground for GermsItchy Skin Common Alongside Kidney DiseaseMany Misdiagnosed With MSVehicle Exhaust Drives Millions of New Asthma Cases AnnuallyNFL Retirees Help Scientists Develop Early Test for Brain Condition CTEMigraine Pain Linked to Raised Suicide RiskMore Time Spent in Sports, Faster Healing From ConcussionHealth Tip: Thermometer OptionsStill No Source as E. Coli Outbreak Grows to 96 Cases Across 5 States: CDCClimate Change Could Worsen Sneezin' SeasonEvenity Approved for Osteoporotic WomenNYC Declares Public Health Emergency Over Brooklyn Measles OutbreakInsurers' Denials of Opioid Coverage Spurs CDC to Clarify GuidelinesImmune-Targeted Treatment Might Help Prevent Peanut Allergy CrisesCluster of Dangerous Antibiotic-Resistant E. Coli Infection Spotted in NYCHealth Tip: Managing Chronic MigrainesFor One Man, Too Much Vitamin D Was DisastrousCDC Investigates Mystery E. Coli Outbreak Affecting 5 StatesBlacks Live Longer, Not Necessarily Better, With ALSIs It Heartburn or Something Else?Lungs, Hearts Infected With Hepatitis C Still OK for TransplantUnhealthy Diets May Be World's Biggest KillerSevere 'Mono' Infection May Raise Risk for Chronic Fatigue SyndromeUnder-the-Tongue Allergy Pills Replacing Shots for Many
Questions and AnswersVideosLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Drug Combo Does Double Duty Against Common Skin Lesions, Cancers

HealthDay News
by -- Robert Preidt
Updated: Mar 21st 2019

new article illustration

THURSDAY, March 21, 2019 (HealthDay News) -- Tens of millions of Americans develop sun-linked skin lesions called actinic keratoses, which are tied to later cancer risk.

Many will get a combo of treatments to help clear the blemishes.

Now, research shows that the same two-ointment combo -- one used to ward off skin cancer and the other a psoriasis drug -- also greatly reduce the odds for squamous cell carcinomas (SCCs), the second most common form of skin cancer.

In the new trial, use of the psoriasis treatment calcipotriol, plus 5-fluorouracil (5-FU) cream, cut the odds for these cancers on the face and scalp by nearly 75 percent, researchers said. Both drugs are already approved by the U.S. Food and Drug Administration.

"This is groundbreaking and will change many lives," said one dermatologist, Dr. Michele Green, who wasn't involved in the new research.

"According to the Skin Cancer Foundation, more than 58 million Americans are affected by actinic keratosis and more than a million are affected by squamous cell carcinoma," noted Green, who practices at Lenox Hill Hospital in New York City.

She believes the combo therapy will prove "very effective" against both conditions.

The new study was led by Dr. Shawn Demehri of the Center for Cancer Immunology at Massachusetts General Hospital in Boston.

In prior research, his team found that twice-daily treatment for four days with a combination of calcipotriol and 5-FU creams significantly reduced the number and size of actinic keratosis lesions.

The new study followed up on 72 of the 130 participants from the first study, to see if the same approach might cut the risk of squamous cell carcinomas.

Three years after treatment, 28 percent of those treated with only 5-FU cream had developed SCC on the face and scalp. But that number was only 7 percent for those who got both medicines, Demehri's group reported.

The combo treatment did not reduce the risk of SCC on the arms, however. The researchers theorized that a longer treatment period may be needed to cut the odds of SCC on the arms and other parts of the body besides the face and scalp.

The study was published online March 20 in the journal JCI Insight.

Dr. Scott Flugman, a dermatologist at Northwell Health's Huntington Hospital in Huntington, N.Y., was also impressed by the new findings.

"Treatment of actinic keratoses has long been established to be medically necessary," he explained.

"Although the risk of any individual lesion transforming into squamous cell carcinoma is only 1 to 2 percent, that risk increases dramatically in patients who have areas of the skin that are literally covered with actinic keratoses," Flugman said. "A 1 percent risk sounds small, but when a patient has dozens or hundreds of these lesions, the risk of developing a skin cancer becomes very high."

He said there are multiple ways to treat actinic keratoses, but some are either expensive, time-consuming or both.

So, "the new study accomplishes two novel objectives," said Flugman, who did not take part in the research. "It reduces treatment time to four days, which is much more manageable for patients. And it does this by combining two well-established, generic medications [5-FU and calcipotriol] that are typically covered on most insurance plans."

Given all that, the combo therapy "has the potential to become a widely adopted treatment method," Flugman said.

Study author Demehri agreed.

"The primary reason for treating actinic keratosis is to prevent [cancer] development, and our findings suggest this immunotherapy may be an effective way of achieving that goal," he said in an MGH news release.

Demehri also believes the finding that immunotherapy for precancerous lesions could prevent cancer "may be applicable to other organs than the skin, something we hope to investigate for malignancies such as breast cancer, for which immunoprevention is an urgent, unmet need."

More information

The U.S. National Cancer Institute has more on skin cancer prevention.




Facebook

Amazon Smile

To quit smoking, call Connecticut QuitLine at 1-800-QUIT-NOW.

Children and Adult services are available now with no wait time.  Please contact HBH Intake Department at 860-548-0101, option 2.

 


powered by centersite dot net